CHAPEL HILL, NC – Four promising faculty members in diverse fields have been awarded the Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement by Young Faculty at the University of North Carolina at Chapel Hill. They are James Bear, PhD, associate professor of cell and developmental biology in the School of Medicine; Yufeng … Read more
UNC’s Goldberg a Key Contributor
CHAPEL HILL, NC – Pancreatic cancer is one of the most challenging tumors to treat. Identifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding from scientists at UNC Lineberger Comprehensive Cancer Center may help. The team analyzed gene profiles of pancreatic tumors from patients with … Read more
Strategic Partnership to Advance Nanotechnology-Based Diagnosis and Treatment
CHAPEL HILL, NC – UNC Lineberger is one of only ten sites in the United States, and the only site in North Carolina, working on a new Phase II clinical trial testing whether a PARP inhibitor is effective in treating recurrent ovarian cancer. The UNC-led trial is being carried out in conjunction with Abbot Laboratories. … Read more
CHAPEL HILL, NC – Ralph Baric, PhD, professor of epidemiology at UNC Gillings School of Global Public Health and a member of UNC Lineberger Comprehensive Cancer Center, has been elected to the American Academy for Microbiology. He will be recognized at the Academy Fellows luncheon in San Diego on May 26, 2010. Dr. Baric and … Read more
CHAPEL HILL, N.C. – Kim Rathmell, MD, PhD, assistant professor of medicine, will receive one of three INNOVATOR awards given by the American Association for Cancer Research and the Kirk A. and Dorothy P. Landon Foundation. The awards will be presented at the AACR’s 101st annual meeting on April 17-21 in Washington, DC. Rathmell, a … Read more
CHAPEL HILL, N.C. – A clinical trial led by UNC Lineberger physician-researcher Mark Socinski, MD has shown that Abraxane® — a chemotherapy agent previously used for metastatic breast cancer – is effective as a first-line treatment for patients with advanced non-small cell lung cancer. The Phase 3 trial, which was conducted at UNC and 101 … Read more
CHAPEL HILL, N.C. – Chemist Joseph DeSimone, PhD, of the University of North Carolina at Chapel Hill has been honored by the American Chemical Society for his outstanding contributions to chemistry research.DeSimone received the Harrison Howe Award, named for one of the founders of the society’s Rochester section. Howe was the founding editor of Chemical … Read more
CHAPEL HILL, NC – A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.
